ctrl K

Watchlist Price Alert

Candel Therapeutics Inc. (CADL)

NASDAQ: CADL · Real-Time Price · USD

6.04

0.49 (8.83%)

At close: Jun 06, 2025, 3:59 PM

6.04

0.00%

Pre-market: Jun 09, 2025, 07:22 AM EDT

Candel Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	125K	125K	125K	125K
Cost of Revenue	990K	23.98M	987K	232K	n/a	6.61M
Gross Profit	n/a	-23.98M	-862K	-107K	125K	-6.48M
Operating Income	-33.37M	-38.39M	-34.72M	-25.73M	-13.81M	-9.04M
Interest Income	1.09M	n/a	490K	53K	111K	1.07M
Pretax Income	-55.18M	-37.94M	-18.79M	-36.12M	-17.68M	-8.24M
Net Income	-55.18M	-37.94M	-2.87M	-36.18M	-22.17M	-8.01M
Selling & General & Admin	14.06M	14.41M	14.06M	10.67M	5.18M	2.56M
Research & Development	19.31M	24.51M	20.79M	15.18M	8.75M	6.61M
Other Expenses	n/a	-24.51M	-48K	-1.08M	-624K	-571K
Operating Expenses	33.37M	14.41M	34.8M	24.77M	13.31M	8.59M
Interest Expense	2.09M	514K	490K	53K	n/a	n/a
Selling & Marketing Expenses	n/a	687K	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	38.39M	34.8M	24.77M	13.31M	8.59M
Income Tax Expense	n/a	n/a	-15.93M	53K	4.49M	-226K
Shares Outstanding (Basic)	31.68M	28.94M	28.82M	28.69M	29.15M	29.15M
Shares Outstanding (Diluted)	31.68M	28.94M	28.82M	28.69M	29.15M	29.15M
EPS (Basic)	-1.74	-1.31	-0.1	-1.26	-0.76	-0.27
EPS (Diluted)	-1.74	-1.31	-0.1	-1.26	-0.76	-0.27
EBITDA	-52.1M	-37.43M	-17.32M	-25.49M	-13.72M	-8.2M
EBIT	-53.09M	-38.39M	-18.3M	-24.65M	-13.19M	-8.47M
Depreciation & Amortization	990K	960K	987K	232K	91K	43K